Results 21 to 30 of about 25,687 (255)

Effect and Mechanism of Herbal Medicines on Cisplatin-Induced Anorexia

open access: yesPharmaceuticals, 2022
Cisplatin is a well-known chemotherapeutic agent used to treat various types of cancers; however, it can also induce anorexia, which results in reduced food intake, loss of body weight, and lower quality of life.
Daeun Min   +3 more
doaj   +1 more source

Daemonorops draco Blume Induces Apoptosis Against Acute Myeloid Leukemia Cells via Regulation of the miR-216b/c-Jun

open access: yesFrontiers in Oncology, 2022
Daemonorops draco Blume (DD), also called dragon’s blood, has been used as a traditional Korean medicine, especially for relieving pain caused by wound infection. Recently, it has been described that DD has antibacterial and analgesic effects.
Moon Nyeo Park   +11 more
doaj   +1 more source

Drug Repositioning Using Temporal Trajectories of Accompanying Comorbidities in Diabetes Mellitus [PDF]

open access: yesEndocrinology and Metabolism, 2022
Background Most studies of systematic drug repositioning have used drug-oriented data such as chemical structures, gene expression patterns, and adverse effect profiles.
Namgi Park   +4 more
doaj   +1 more source

BK002 Induces miR-192-5p-Mediated Apoptosis in Castration-Resistant Prostate Cancer Cells via Modulation of PI3K/CHOP

open access: yesFrontiers in Oncology, 2022
BK002 consists of Achyranthes japonica Nakai (AJN) and Melandrium firmum Rohrbach (MFR) that have been used as herbal medicines in China and Korea. AJN and MFR have been reported to have anti-inflammatory, anti-oxidative, and anti-cancer activities ...
Moon Nyeo Park   +17 more
doaj   +1 more source

Drug repositioning [PDF]

open access: yesInternational Journal of Epilepsy, 2016
AbstractRapid advances in pharmacotherapy and bioinformatics has led to the discovery and growing popularity of drug repositioning which includes re-investigating or recycling of existing drugs for new indications. There are innumerable advantages as well as challenges of drug repositioning. Since de-novo drug discovery takes plenty of time, effort and
Man Mohan Mehndiratta   +4 more
openaire   +1 more source

Drug target gene-based analyses of drug repositionability in rare and intractable diseases

open access: yesScientific Reports, 2021
Drug development for rare and intractable diseases has been challenging for decades due to the low prevalence and insufficient information on these diseases. Drug repositioning is increasingly being used as a promising option in drug development.
Ryuichi Sakate, Tomonori Kimura
doaj   +1 more source

Computational drug repositioning with attention walking

open access: yesScientific Reports
Drug repositioning aims to identify new therapeutic indications for approved medications. Recently, the importance of computational drug repositioning has been highlighted because it can reduce the costs, development time, and risks compared to ...
Jong-Hoon Park, Young-Rae Cho
doaj   +3 more sources

Drug repositioning for personalized medicine [PDF]

open access: yesGenome Medicine, 2012
Human diseases can be caused by complex mechanisms involving aberrations in numerous proteins and pathways. With recent advances in genomics, elucidating the molecular basis of disease on a personalized level has become an attainable goal. In many cases, relevant molecular targets will be identified for which approved drugs already exist, and the ...
Li, Yvonne Y, Jones, Steven JM
openaire   +2 more sources

A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions

open access: yesJournal of Cheminformatics, 2020
Drug repositioning is the process of identifying novel therapeutic potentials for existing drugs and discovering therapies for untreated diseases. Drug repositioning, therefore, plays an important role in optimizing the pre-clinical process of developing
Tamer N. Jarada   +2 more
doaj   +1 more source

Transcriptome-Guided Drug Repositioning [PDF]

open access: yesPharmaceutics, 2019
Drug repositioning can save considerable time and resources and significantly speed up the drug development process. The increasing availability of drug action and disease-associated transcriptome data makes it an attractive source for repositioning studies.
Arsen Arakelyan   +7 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy